Industry Educational Session - Guidelines in action: Practical implications of changing standards of care for treatment of DLBCL - Sponsored by Gilead
Tracks
-
| Sunday, April 27, 2025 |
| 12:35 PM - 1:20 PM |
| Alsh |
Details
A practical and interactive session focused on equitable, guideline-concordant treatment for patients with R/R DLBCL, including sequencing considerations for patients who progress to 3L and beyond, based upon anticipated updates to the BSH guidelines
Gilead products will be discussed during the symposium.
UKI-YES-0149 March 2025
Speaker
Dr Cathy Burton
Consultant Haematologist
Leeds Teaching Hospitals NHS Trust
- Consultant Haematologist at St James’s University Hospital, Leeds, specialising in Lymphoma and Diagnostics
Dr Sridhar Chaganti
Consultant Haematologist
University Hospital Birmingham
- Consultant haemato-oncologist at the University Hospital Birmingham (UHB), with an interest in lymphomas, ALL, stem cell transplantation and immune effector cell therapies including CART cell therapy
Dr Kathryn Thorton
Consultant Haematologist
Mid Yorkshire Teaching NHS Trust
- Consultant haematologist at Mid Yorkshire NHS trust in Wakefield.
